Canada Markets close in 4 hrs 14 mins

Medicure Inc. (MPH.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.93000.0000 (0.00%)
As of 11:24AM EST. Market open.
Full screen
Previous Close0.9300
Open0.9300
Bid0.9900 x 0
Ask1.1000 x 0
Day's Range1.0000 - 1.0000
52 Week Range0.8200 - 2.0100
Volume85
Avg. Volume1,447
Market Cap9.534M
Beta (5Y Monthly)0.95
PE Ratio (TTM)N/A
EPS (TTM)-0.6100
Earnings DateAug. 09, 2021 - Aug. 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Algernon Pharmaceuticals Announces New Chief Financial Officer

    VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has appointed Mr. James Kinley as the Company’s Chief Financial Officer (“CFO”), effective December 1, 2021. Mr. Kinley will report to Algernon’s Chief Executive Officer (“CEO”) Mr. Christopher J. Moreau. Mr. Kinley is a Certified Professional Account

  • CNW Group

    Medicure Reports Financial Results for Quarter Ended September 30, 2021

    Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended September 30, 2021.

  • CNW Group

    Medicure Plans To Launch Innovative E-Commerce Pharmacy Platform Offering Hundreds of Medications Directly To Millions of Americans

    Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, is pleased to announce that it is planning to launch a national direct-to-consumer E-Commerce pharmacy platform through its subsidiary, Marley Drug™ pharmacy, before the end of 2021.